@article{d942db33df1441daa7b83ac944c27b6c,
title = "Defining a longevity biotechnology company",
author = "Nicola Boekstein and Nir Barzilai and Andr{\'e} Bertram and Joe Betts-LaCroix and Kristen Fortney and Helliwell, {Stephen B.} and Michael Hufford and Joan Mannick and Jerry McLaughlin and Jim Mellon and Eric Morgen and Nils Regge and Robinton, {Daisy A.} and Sinclair, {David A.} and Sergey Young and Risa Starr and Alex Zhavoronkov and James Peyer",
note = "Funding Information: All authors of this paper are members of the LBA. The LBA{\textquoteright}s mission is to sponsor longevity industry and investor meetings and webcasts, connect stakeholders in the field, and provide industry and scientific education to its members. The LBA is a global non-profit, comprising a network of longevity biotechnology companies, researchers and investors. This Correspondence has been reviewed and approved by the members of the LBA. The LBA provided funding for the initial meeting of authors to discuss the ideas of the paper. No further financial support was received by the authors for the research, authorship and publication of this article.",
year = "2023",
month = aug,
doi = "10.1038/s41587-023-01854-0",
language = "English (US)",
volume = "41",
pages = "1053--1055",
journal = "Nature biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "8",
}